Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Equity Ratio: 2016-2024

Historic Equity Ratio for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to 0.53.

  • Organogenesis Holdings' Equity Ratio fell 19.82% to 0.50 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.50, marking a year-over-year decrease of 19.82%. This contributed to the annual value of 0.53 for FY2024, which is 12.83% down from last year.
  • Organogenesis Holdings' Equity Ratio amounted to 0.53 in FY2024, which was down 12.83% from 0.61 recorded in FY2023.
  • In the past 5 years, Organogenesis Holdings' Equity Ratio ranged from a high of 0.61 in FY2023 and a low of 0.49 during FY2020.
  • Over the past 3 years, Organogenesis Holdings' median Equity Ratio value was 0.59 (recorded in 2022), while the average stood at 0.58.
  • Per our database at Business Quant, Organogenesis Holdings' Equity Ratio surged by 94.00% in 2020 and then dropped by 12.83% in 2024.
  • Yearly analysis of 5 years shows Organogenesis Holdings' Equity Ratio stood at 0.49 in 2020, then climbed by 11.43% to 0.54 in 2021, then rose by 8.59% to 0.59 in 2022, then grew by 2.46% to 0.61 in 2023, then dropped by 12.83% to 0.53 in 2024.